Surveillance Strategies for Renal Cell Carcinoma in the Renal Allograft: Balancing Early Detection and Resource Utilization
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Goujon A, Verhoest G, Sallusto F, Branchereau J, Boutin J, Bessede T
. [Renal cell carcinoma in candidates for renal transplantation and recipients of a kidney transplant: The French guidelines from CTAFU]. Prog Urol. 2021; 31(1):18-23.
DOI: 10.1016/j.purol.2020.04.030.
View
2.
Farber N, Kim C, Modi P, Hon J, Sadimin E, Singer E
. Renal cell carcinoma: the search for a reliable biomarker. Transl Cancer Res. 2017; 6(3):620-632.
PMC: 5538266.
DOI: 10.21037/tcr.2017.05.19.
View
3.
Kasiske B, Snyder J, Gilbertson D, Wang C
. Cancer after kidney transplantation in the United States. Am J Transplant. 2004; 4(6):905-13.
DOI: 10.1111/j.1600-6143.2004.00450.x.
View
4.
Doublet J, Peraldi M, Gattegno B, Thibault P, Sraer J
. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol. 1997; 158(1):42-4.
DOI: 10.1097/00005392-199707000-00012.
View
5.
Fu Y, Zhong J, Tan Y, Zheng T, Liu M, Wang G
. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients. Sci Rep. 2024; 14(1):11409.
PMC: 11102535.
DOI: 10.1038/s41598-024-62496-z.
View